Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Crit Care, Oncology & Hematology > Lymphoma > Flashcards

Lymphoma Flashcards

1
Q

What is a major difference between Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma?

A

Hodgkin’s: minority, binomial ages (younger and old!)
Non-Hodgkin’s: majority, occurs as B/T/NK cell
- Graded based on disease progression + aggression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are all the risk factors for lymphoma?

A

Male
Old age
Immunosuppression
Infections
Environmental exposures
Radiation
Epstein-Barr
HIV

[my old ignorant in-law expect rich eloquent housewives]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common type of Non-Hodgkin’s lymphoma?

A

Diffuse Large B-cell Lymphoma (B-cell lymphoma is most common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is Non-Hodgkin’s lymphoma classified?

A

Classified by step in cell maturation process where mutation occurs
(“Cell of origin”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the clinical presentation of Diffuse Large B-Cell Lymphoma?

A

B-symptoms (FEVER, NIGHT SWEATS, WEIGHT LOSS)
Nodal masses (nodes full of immature cells)
Increased Lactate Dehydrogenase (cell turnover marker, since lymph nodes swell and cause cell lysis)
Bone marrow involvement
Altered mental status
Increased SCr, uric acid, liver enzymes, electrolytes (tumor lysis syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the specific risk factors for Non-Hodgkin’s lymphoma?

A

Immunosuppression
Environmental factors
Radiation exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is required for the diagnosis of Non-Hodgkin’s lymphoma?

A

LYMPH NODE BIOPSY - confirm various mutations including CD20
Imaging- PET, CT scans
Assess cell of origin (Germinal (favorable) or Activated?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

For prognosis assessment of Non-Hodgkin’s lymphoma, what tool is used? What factors are involved with assessment?

A

International Prognostic Index (IPI)
Age (older = worse)
Lactate dehydrogenase (>3 is bad)
Extranodality
Performance status
Overall risk grouping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the TWO preferred treatment regimens of Non-Hodgkin’s?

A

R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)
Pola-R-CHP (Polatuzumab vedotin, Rituximab, Cyclophosphamide, Doxorubicin, Prednisone)

H = Doxarubicin, O = Vincristine, don’t question it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is an alternative to R-CHOP/Pola-R-CHP for Non-Hodgkin’s treatment?

A

DA-R-EPOCH (Dose Adjusted Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a Non-Hodgkin’s patient has poor LV ejection fraction, what are preferred first line treatments?

A

DA-R-EPOCH (contains cardiotoxic drug Doxorubicin but slower infusion is ok!)

Alts:
- R-CDOP (rituximab, cyclophosphamide, liposomal doxorubicin, prednisone)
- R-GCVP (rituximab, gemcitabine, cyclophosphamide, vincristine, prednisone)
- R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If a Non-Hodgkin’s patient is frail or >80 yo, what is the preferred first line treatment?

A

R-mini CHOP
(Lower intensity R-CHOP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If a Non-Hodgkin’s patient has concurrent CNS disease, what are preferred first line treatments?

A

Lumbar punctures with chemo
High dose methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are two considerations of using CHOP in Non-Hodgkin’s?

A

HIGH emetic risk! (PRN antiemetics)
Moderate febrile neutropenia risk (consider G-CSF after chemo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some AEs with CHOP therapy in Non-Hodgkin’s?

A

Infections, fatigue anemia, thrombocytopenia, alopecia
Doxorubicin: cardiotoxicity (anthracycline, limit max lifetime dose <500)
Vincristine: peripheral neuropathy
Cyclophosphamide: hemorrhagic cystitis
Prednisone: insomnia, GI upset, high BG (steroid effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

After CHOP, how long should prednisone be continued (including day of chemo)?

A

5 days prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many cycles of CHOP are usually used in Non-Hodgkin’s? What is the maximum vincristine that can be given in any one cycle?

A

6 cycles of 21 days
Vincristine = 2 mg maximum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For CD20-positive Non-Hodgkin’s patients, what drug is used? When do we give it timing-wise?

A

Rituxumab (basically everyone gets)
Administered before CHOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are some AEs from using Rituxumab (Non-Hodgkin’s drugs)

A

Infusion rxn (PREMEDICATE w APAP and Benadryl, first cycle titration = 6 hrs!)
Hepatitis B reactivation (check hepatitis panel before use)
Hypogammaglobulinemia/infections
GI perforations (consider holding Rituxumab)
Rare - PML

20
Q

What did the MInT study find? (Non-Hodgkin’s)

A

R-CHOP vs CHOP
Rituxumab had significant improvement wo increased toxicity

21
Q

How is DA-R-EPOCH administered? What is the one difference between typical R-CHOP and this?

A

Administered as infusion for 4 days then on Day 5 only cyclophosphamide bolus

One difference = Etoposide included

22
Q

DA-R-EPOCH has ________ lab checks for pt’s ____ and _______. If these are too LOW, then what do we do? If too HIGH?

A

2x/week lab checks for PLTs andd ANC!

INCREASED PLT/ANC = increase dose
DECREASED PLT/ANC = decrease dose

23
Q

When should DA-R-EPOCH treatment be considered? (Non-Hodgkin’s) What must ALWAYS be given with this treatment?

A

Double/Triple hit high grade B cell lymphoma
Poor LVEF
ALWAYS give G-CSF following completion of each chemo cycle

24
Q

What is given in the alternative R-CHOP therapy instead of vincristine? Why?
Is this alternative superior to R-CHOP?

A

Polatuzumab vedotin given instead of vincristine
Eliminates synergy with vedotin and worsening peripheral neuropathy
Non-superior to R-CHOP, but also not worse

25
Q

What are some AEs of Polatuzumab (Non-Hodgkin’s)?

A

Peripheral neuropathy, constipation, skeletomuscular pain, infusion reactions, anemia, thrombocytopenia, neutropenia

26
Q

30-40% of Non-Hodgkin’s patients relapse; what are possible REFRACTORY treatments?

A

Salvage therapy chemo (R-ICE, GDP)
Autologous Stem Cell Transplant
Chimeric Antigen Receptor Therapy (CAR-T)
Bispecific mAb

27
Q

What is Chronic Lymphocytic Leukemia (CLL)

A

Accumulation of immunologically dysfunctional B cells
MOST common type of leukemia

28
Q

What is the clinical presentation of chronic lymphocytic leukemia?

A

Mostly asymptomatic
(If symptomatic:
Enlarged lymph nodes
Enlarged spleen/liver
B-symptoms [fever, night sweats, weight loss]
Autoimmune cytopenia
Hypogammaglobulinemia)

29
Q

What two mutations are indicative of WORSE prognosis in chronic lymphocytic leukemia?

A

del(17p)
TP53

30
Q

While most people are asymptomatic, what are indications for treatment in CLL?

A

Disease-related sx (severe fatigue, weight loss, night sweats)
End organ dysfunction
Bulky disease (splenomegaly/lymphadenopathy)
Bone marrow failure
Anemia, thrombocytopenia (unresponsive to corticosteroids)
Increase in absolute lymphocyte count (ALC) ≥50% over 2 months
Extranodal involvement

31
Q

Who should get FIXED treatment vs INDEFINITE treatment for CLL?

A

FIXED: Younger, fit patients
INDEFINITE: Elderly, less fit patients

32
Q

What is the FIXED treatment for normal TP53 mutations and TP53/del(17p) mixed mutations?

A

Obinutuzumab + venetoclax

33
Q

What is the INDEFINITE treatment for normal TP53 mutations and TP53/del(17p) mixed mutations?

A

Acalabrutinib +/- [obinutuzumab OR zanubrutinib]

34
Q

What drug is CCL drug Obinutuzumab similar to? What are some AEs?

A

Similar to RITUXUMAB (like in R-CHOP)
AEs: infusion reactions, Hepatitis B reactivation, increase viral infection risk

35
Q

What are Bruton Tyrosine Kinase Inhibitors (BTKi)? (CLL) Name the three that we use.

A

Block B-cell receptor signaling cascade by binding to BTK enzyme and stops further creation of B cells
Second gen BTKis are more selective for cysteine 481 (less “off-target” effects)

1st gen = Ibrutinib
2nd gen = Acalabrutinib, Zanubrutinib

36
Q

What are some major AEs for the BTKis in CLL. What is one clinical pearl?

A

Ibrutinib = Neutropenia, HTN, arrhythmia
Acalabrutinib = HAs, muscle pain (“push through”, will self-resolve; consider APAP for relief)
Zanubrutinib = Myelosuppression, contusions (much less arrhythmia)=

Pearl: transient increase in absolute lymphocyte count at start, does not mean worsening disease

37
Q

With Hodgkin’s lymphoma, there is a spike in ___ and _____ patients. They are characterized by _________ cells, which are B cells with 2 nuclei!

A

Spike in younger and older pts
Characterized by Reed-Sternberg cells

38
Q

What is the clinical presentation of Hodgkin’s lymphoma?

A

B-symptoms (FEVER, NIGHT SWEATS, WEIGHT LOSS)
Lymphadenopathy (CD30 (+), usually in neck/underarm)
Generalized malaise (cough, SoB, less appetite)

39
Q

What lymphoma risk factors are specific to Hodgkin’s lymphoma?

A

Younger/Older age
Epstein-Barr Virus
HIV infection

40
Q

What factors could indicate a worse prognosis for Hodgkin’s lymphoma?

A

≥45 yo
Male
Stage 4 bone marrow biopsy
Albumin < 4
Hgb < 10.5
WBC > 15,000
Lymphocytopenia

41
Q

What is the GOLD STANDARD treatment for Hodgkin’s lymphoma?

A

ABVD
(Doxorubicin (A, dont question), Bleomycin, Vinblastine (similar to vincristine) Dacarbazine
Given every 14 days

Advanced stage can add targeted therapies like Brentuximab vedotin (like Polatuzumab!)

42
Q

What are some risks with using ABVD therapy in Hogkin’s? What are some AEs?

A

Considerations: High emetic risk, febrile neutropenia
AEs:
Doxorubicin - cardiotoxicity
Bleomycin - pulmonary toxicity especially with growth factor
Vinblastine - peripheral neuropathy (like vincristine)
Dacarbazine - cytopenias

(Try to minimize Bleomycin use if possible! Quite toxic)

43
Q

What is the method to decrease Bleomycin usage in ABVD regimens (Hodgkin’s)?

A

Conduct a PET scan after 2 cycles ABVD
If PET score 1-3, may deescalate to AVD for remaining 4 cycles

44
Q

What is Brentuximab vedotin? When is it used? What must be given with it?

A

Anti-CD30 Ab conjugate
Used in ADVANCED HODGKIN’S LYMPHOMA
Given with rituximab, cyclophosphamide, doxorubicin, prednisone
MUST be given with GROWTH FACTOR plus AVD standard therapy

45
Q

What are some refractory Hodgkin’s treatments?

A

Salvage therapy - ICE, GVD
Autologous Stem Cell transplant
Immunotherapy (Pembrolizumab/nivolumab)

46
Q

Before starting a Rituxumab-inclusion therapy, what kind of Hepatitis-B panel are we looking for? What would be the prophylaxis for HBV reactivation?

A

HBsAg (+)
Anti-HBc (+)
IgM Anti-HBc (-)
Anti-HBs (-)

indicates chronic HBV infection
Give entecavir 0.5mg po for prophylaxis

Crit Care, Oncology & Hematology (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions